SCHEMBL30545679

SCHEMBL30545679

C=CS(=O)(=O)NCc1ccn(Cc2cc(OC)c3c(NS(=O)(=O)c4ccccc4OC)noc3c2)n1

nearest known ligand 0.62

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KAT7 O95251 20/20 0.62
KAT6A Q92794 20/20 0.62
KAT6B Q8WYB5 13/20 0.60
KAT5 Q92993 13/20 0.60
KAT8 Q9H7Z6 13/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26075903 1.00 KAT7 (0.62) KAT7KAT6AKAT6BKAT5KAT8
SCHEMBL26073891 0.94 KAT7 (0.54) KAT7KAT6AKAT6BKAT5KAT8
SCHEMBL26074586 0.93 KAT7 (0.60) KAT7KAT6AKAT6BKAT5KAT8
SCHEMBL30545658 0.93 KAT7 (0.60) KAT7KAT6AKAT6BKAT5KAT8
SCHEMBL30545673 0.92 KAT7 (0.71) KAT7KAT6AKAT6BKAT5KAT8
SCHEMBL26075881 0.92 KAT7 (0.71) KAT7KAT6AKAT6BKAT5KAT8
SCHEMBL26077201 0.89 KAT7 (0.62) KAT7KAT6AKAT6BKAT5KAT8
SCHEMBL26074581 0.88 KAT7 (0.60) KAT7KAT6AKAT6BKAT5KAT8
SCHEMBL30545757 0.88 KAT7 (0.53) KAT7KAT6AKAT6BKAT5KAT8
SCHEMBL26073887 0.88 KAT7 (0.53) KAT7KAT6AKAT6BKAT5KAT8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4499609-A1 INHIBITORS OF THE MYST FAMILY OF LYSINE ACETYL TRANSFERASES Isosterix, Inc. (US) 2025-02-05 EP disclosed
CN-119301096-A Inhibitors of MYST family lysine acetyltransferase 伊索斯泰里克斯公司 2025-01-10 CN disclosed
WO-2023192817-A9 INHIBITORS OF THE MYST FAMILY OF LYSINE ACETYL TRANSFERASES Isosterix, Inc. (US) 2024-10-03 WO disclosed
WO-2023192817-A1 INHIBITORS OF THE MYST FAMILY OF LYSINE ACETYL TRANSFERASES Isosterix, Inc. (US) 2023-10-05 WO disclosed